이 페이지는 자동 번역되었으며 번역의 정확성을 보장하지 않습니다. 참조하십시오 영문판 원본 텍스트의 경우.

현실을 경험해 보세요: 소아 줄기 세포 이식 및 세포 치료에 대한 가족 건강 커뮤니케이션 도구

2026년 11월 16일 업데이트: Washington University School of Medicine

실제 시작: 소아 줄기 세포 이식 및 세포 치료에 대한 가족 건강 커뮤니케이션 도구의 파일럿 시험

The investigators will conduct a pilot feasibility and efficacy trial of a newly developed family health communication tool (called Let's Get REAL) in increasing youth involvement in real-time stem cell transplant and cellular therapy decisions (SCTCT). The investigators will pilot the intervention among 24 youth and their parents, stratified by youth age (stratum 1, 8-12 years of age and stratum 2, 13-17 years of age).

연구 개요

연구 유형

중재적

등록 (추정된)

60

단계

  • 해당 없음

연락처 및 위치

이 섹션에서는 연구를 수행하는 사람들의 연락처 정보와 이 연구가 수행되는 장소에 대한 정보를 제공합니다.

연구 연락처

  • 이름: Ginny L Schulz, Ph.D., RN, CPNP-PC
  • 전화번호: 314-454-6018
  • 이메일: schulz_g@wustl.edu

연구 장소

    • Missouri
      • St Louis, Missouri, 미국, 63110
        • 모병
        • Washington University School of Medicine
        • 부수사관:
          • Shalini Shenoy, M.D.
        • 연락하다:
          • Ginny L Schulz, Ph.D., RN, CPNP-PC
          • 전화번호: 314-454-6018
          • 이메일: schulz_g@wustl.edu
        • 수석 연구원:
          • Ginny L Schulz, Ph.D., RN, CPNP-PC
        • 부수사관:
          • Amy McQueen, Ph.D.

참여기준

연구원은 적격성 기준이라는 특정 설명에 맞는 사람을 찾습니다. 이러한 기준의 몇 가지 예는 개인의 일반적인 건강 상태 또는 이전 치료입니다.

자격 기준

공부할 수 있는 나이

8년 이상 (어린이, 성인, 고령자)

건강한 자원 봉사자를 받아들입니다

아니

연구 대상 성별

모두

설명

Inclusion Criteria Youth:

  • Children or adolescents 8-17 years of age referred for SCTCT.
  • Diagnosis of malignant or nonmalignant disorder.
  • Referred for any type of SCTCT. Autologous and allogeneic stem cell and cellular therapies are eligible.
  • Planning to meet with a provider to discuss SCTCT.
  • Must have the ability to understand and willingness to consent to participate after reviewing an IRB approved informed assent document.
  • Must speak English and be cognitively able to participate.

Inclusion Criteria Parents:

  • Parent or guardian of a child 8-17 years of age with any diagnosis referred for any type of SCTCT. Diagnoses may include malignant and nonmalignant disorders. Autologous and allogeneic stem cell and cellular therapies are eligible. Parent or guardian is defined as an adult who usually cares for the youth and has authority to make medical decisions for them.
  • Must have the ability to understand and willingness to consent to participate after reviewing an IRB approved informed consent document.
  • Must speak English and be cognitively able to participate.

Exclusion Criteria Youth:

  • Active medical problems severe enough to preclude study participation at the time of recruitment.

    • Patients who are otherwise eligible, but whose primary transplant physician does not want them to participate in the study.
  • Lacks cognitive capacity to complete study activities, as determined by consenting professional.

Exclusion Criteria Parents:

  • Their youth referred for SCTCT does not assent to participate.

공부 계획

이 섹션에서는 연구 설계 방법과 연구가 측정하는 내용을 포함하여 연구 계획에 대한 세부 정보를 제공합니다.

연구는 어떻게 설계됩니까?

디자인 세부사항

  • 주 목적: 건강 서비스 연구
  • 할당: 무작위화되지 않음
  • 중재 모델: 병렬 할당
  • 마스킹: 없음(오픈 라벨)

무기와 개입

참가자 그룹 / 팔
개입 / 치료
실험적: Let's Get REAL family health communication tool: Patients (8-12 years of age)

Patients and parent(s) will be given the Let's Get REAL family health communication tool to use up to one month prior to their SCTCT consultation visit. It is a guide for pediatric patients and their families to learn about and discuss SCTCT. Participants will complete demographic and baseline surveys prior to using the tool, and then additional surveys up to one month after SCTCT consultation visit and up to one month post-discharge from SCTCT. SCTCT consultation visits will be audio-recorded. Participants may also participate in an optional semi-structured interview up to 8 weeks after SCTCT consultation.

Family health communication tool

실험적: Let's Get REAL family health communication tool: Patients (13-17 years of age)

Patients and parent(s) will be given the Let's Get REAL family health communication tool to use up to one month prior to their SCTCT consultation visit. It is a guide for pediatric patients and their families to learn about and discuss SCTCT. Participants will complete demographic and baseline surveys prior to using the tool, and then additional surveys up to one month after SCTCT consultation visit and up to one month post-discharge from SCTCT. SCTCT consultation visits will be audio-recorded. Participants may also participate in an optional semi-structured interview up to 8 weeks after SCTCT consultation.

Family health communication tool

실험적: Let's Get REAL family health communication tool: Parents

Patients and parent(s) will be given the Let's Get REAL family health communication tool to use up to one month prior to their SCTCT consultation visit. It is a guide for pediatric patients and their families to learn about and discuss SCTCT. Participants will complete demographic and baseline surveys prior to using the tool, and then additional surveys up to one month after SCTCT consultation visit and up to one month post-discharge from SCTCT. SCTCT consultation visits will be audio-recorded. Participants may also participate in an optional semi-structured interview up to 8 weeks after SCTCT consultation.

Family health communication tool

연구는 무엇을 측정합니까?

주요 결과 측정

결과 측정
측정값 설명
기간
Feasibility of intervention as measured by the Feasibility of Intervention questionnaire
기간: Up to 4 weeks after SCTCT consultation (estimated to be week 8)

This is a 4-item scale that youth and their parents report feasibility of the intervention on a 5-point Likert scale ranging from 'Completely disagree' to Completely agree'. A higher score indicates greater feasibility.

Up to 4 weeks after SCTCT consultation (estimated to be week 8)
Acceptability of intervention as measured by the Acceptability of Intervention questionnaire
기간: Up to 4 weeks after SCTCT consultation (estimated to be week 8)

This is a 4-item scale that youth and their parents report acceptability of the intervention on a 5-point Likert scale ranging from 'Completely disagree' to Completely agree'. A higher score indicates greater acceptability.

Up to 4 weeks after SCTCT consultation (estimated to be week 8)
Appropriateness of intervention as measured by the Intervention of Appropriateness questionnaire
기간: Up to 4 weeks after SCTCT consultation (estimated to be week 8)

This is a 4-item scale that youth and their parents report appropriateness of the intervention on a 5-point Likert scale ranging from 'Completely disagree' to Completely agree'. A higher score indicates greater appropriateness.

Up to 4 weeks after SCTCT consultation (estimated to be week 8)
Feasibility of intervention as measured qualitatively
기간: Up to 8 weeks after SCTCT consultation (estimated to be week 16)

Content analysis of open-ended survey responses and quotations from individual interviews. Will be collecting number of feasibility content codes.

Up to 8 weeks after SCTCT consultation (estimated to be week 16)
Acceptability of intervention as measured qualitatively
기간: Up to 8 weeks after SCTCT consultation (estimated to be week 16)

Content analysis of open-ended survey responses and quotations from individual interviews. Will be collecting number of acceptability content codes.

Up to 8 weeks after SCTCT consultation (estimated to be week 16)
Appropriateness of intervention as measured qualitatively
기간: Up to 8 weeks after SCTCT consultation (estimated to be week 16)

Content analysis of open-ended survey responses and quotations from individual interviews. Will be collecting number of appropriateness content codes.

Up to 8 weeks after SCTCT consultation (estimated to be week 16)

2차 결과 측정

결과 측정
측정값 설명
기간
SCTCT를 선택한 환자 수
기간: SCTCT 상담 후 최대 4주(8주차 예상)
SCTCT 상담 후 최대 4주(8주차 예상)
Difference in feasibility scores in those 8-12 years of age and those 13-17 years of age as measured by the Feasibility of Intervention questionnaire
기간: Up to 4 weeks after SCTCT consultation (estimated to be week 8)

This is a 4-item scale that youth and their parents report feasibility of the intervention on a 5-point Likert scale ranging from 'Completely disagree' to Completely agree'. A higher score indicates greater feasibility.

Up to 4 weeks after SCTCT consultation (estimated to be week 8)
Difference in acceptability scores in those 8-12 years of age and those 13-17 years of age as measured by the Acceptability of Intervention questionnaire
기간: Up to 4 weeks after SCTCT consultation (estimated to be week 8)

This is a 4-item scale that youth and their parents report acceptability of the intervention on a 5-point Likert scale ranging from 'Completely disagree' to Completely agree'. A higher score indicates greater acceptability.

Up to 4 weeks after SCTCT consultation (estimated to be week 8)
Difference in appropriateness scores in those 8-12 years of age and those 13-17 years of age as measured by the Intervention of Appropriateness questionnaire
기간: Up to 4 weeks after SCTCT consultation (estimated to be week 8)

This is a 4-item scale that youth and their parents report appropriateness of the intervention on a 5-point Likert scale ranging from 'Completely disagree' to Completely agree'. A higher score indicates greater appropriateness.

Up to 4 weeks after SCTCT consultation (estimated to be week 8)
Perceived levels of decision-making involvement in youth 8-17 years of age and their parents as measured by the Decision Making Involvement Scale
기간: Up to 4 weeks after SCTCT consultation (estimated to be week 8)

This is a 30-item scale that youth and their parents report youth involvement behaviors in a decision related to their illness on a 4-point Likert scale ranging from 'A Little Bit' to 'A Lot'. The higher the subscale score (child seek, child express, parent seek, parent express, and joint/options), the more that behavior or type of involvement occurred in the decision making process.

Up to 4 weeks after SCTCT consultation (estimated to be week 8)
Observed levels of decision-making involvement in youth 8-17 years of age and their parents
기간: Up to 4 weeks after SCTCT consultation (estimated to be week 8)

Number of utterance occurrences for the following: 1) who uttered (youth, parent), 2) was utterance prompted (yes/no), if so, by who, 3) type of utterance (questions, opinion, concern, other), and 4) content of utterance (prognosis, side effect, expectation).

Up to 4 weeks after SCTCT consultation (estimated to be week 8)
Change in youth-parent communication as measured by the Likert-type Parent-Adolescent Communication Scale
기간: Up to 4 weeks prior to SCTCT consultation and up to 4 weeks after SCTCT consultation (estimated to be 8 weeks)

This is a 20-item scale that youth and parents report the degree of openness in family communication and the extent of problems with family communications on a 5-point Likert ranging from 'strongly disagree' to 'strongly agree'. A higher score on the degree of openness subscale indicates better communication between parent and adolescent. For extent of problems subscale, a higher score indicates more problems in the parent-child communication.

Up to 4 weeks prior to SCTCT consultation and up to 4 weeks after SCTCT consultation (estimated to be 8 weeks)
Change in the level of youth's general anxiety as measured by the Likert-type PROMIS Anxiety 8a Short Form or parent proxy
기간: Up to 4 weeks prior to SCTCT consultation and up to 4 weeks after SCTCT consultation (estimated to be 8 weeks)

This is an 8-item scale that measures youth's general anxiety in those 8-17 years of age on a 5-point Likert scale ranging from 'never' to 'almost always'.

Up to 4 weeks prior to SCTCT consultation and up to 4 weeks after SCTCT consultation (estimated to be 8 weeks)
Level of decisional conflict as measured by the Likert-type Decisional Conflict Scale
기간: Up to 4 weeks after SCTCT consultation (estimated to be week 8)

This is a 10-item scale that youth and parents report their personal uncertainty and decisional conflict related to a specific decision. We are using the question format as it is recommended for those with limited reading or response skills. They respond 'Yes', 'No, or 'Unsure'. A total decision conflict score ranges from 0 (no decisional conflict) to 100 (extremely high decision conflict). Higher scores on subscales uncertainty, informed, values clarity, and support reflect feeling extremely uncertain about the best choice, feeling extremely uninformed, feeling extremely unclear about personal values, and feeling extremely unsupported in decision making respectively.

Up to 4 weeks after SCTCT consultation (estimated to be week 8)
Youth-parent congruence of youth decision making involvement as measured by two Likert type statements
기간: Up to 4 weeks after SCTCT consultation (estimated to be week 8)

Number of dyads that agree on these two statements measured on a 4-point Likert scale ranging from 'Not at all' to 'A lot': 1)"I/my child should be involved in future talks about transplant" and 2) "I/my child wants to be involved in future talks about transplant".

Up to 4 weeks after SCTCT consultation (estimated to be week 8)
Satisfaction with the decision making involvement as measured by one Likert type statement
기간: Up to 4 weeks after SCTCT consultation (estimated to be week 8)

This is a one item statement, "I am satisfied with my/my child's involvement in the transplant decision making process", measured on a 4-point Likert scale ranging from 'Not at all' to 'A lot'. A higher score indicates more satisfaction.

Up to 4 weeks after SCTCT consultation (estimated to be week 8)

공동 작업자 및 조사자

여기에서 이 연구와 관련된 사람과 조직을 찾을 수 있습니다.

수사관

  • 수석 연구원: Ginny Schulz, Ph.D., RN, CPNP-PC, Washington University School of Medicine

간행물 및 유용한 링크

연구에 대한 정보 입력을 담당하는 사람이 자발적으로 이러한 간행물을 제공합니다. 이것은 연구와 관련된 모든 것에 관한 것일 수 있습니다.

연구 기록 날짜

이 날짜는 ClinicalTrials.gov에 대한 연구 기록 및 요약 결과 제출의 진행 상황을 추적합니다. 연구 기록 및 보고된 결과는 공개 웹사이트에 게시되기 전에 특정 품질 관리 기준을 충족하는지 확인하기 위해 국립 의학 도서관(NLM)에서 검토합니다.

연구 주요 날짜

연구 시작 (실제)

2024년 11월 26일

기본 완료 (추정된)

2027년 8월 31일

연구 완료 (추정된)

2027년 8월 31일

연구 등록 날짜

최초 제출

2024년 11월 12일

QC 기준을 충족하는 최초 제출

2024년 11월 12일

처음 게시됨 (실제)

2024년 11월 14일

연구 기록 업데이트

마지막 업데이트 게시됨 (실제)

2026년 11월 17일

QC 기준을 충족하는 마지막 업데이트 제출

2026년 11월 16일

마지막으로 확인됨

2026년 11월 1일

추가 정보

이 연구와 관련된 용어

개별 참가자 데이터(IPD) 계획

개별 참가자 데이터(IPD)를 공유할 계획입니까?

아니요

약물 및 장치 정보, 연구 문서

미국 FDA 규제 의약품 연구

아니

미국 FDA 규제 기기 제품 연구

아니

이 정보는 변경 없이 clinicaltrials.gov 웹사이트에서 직접 가져온 것입니다. 귀하의 연구 세부 정보를 변경, 제거 또는 업데이트하도록 요청하는 경우 register@clinicaltrials.gov. 문의하십시오. 변경 사항이 clinicaltrials.gov에 구현되는 즉시 저희 웹사이트에도 자동으로 업데이트됩니다. .

구독하다